

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 5.16875756 |
| 2 | * pentose-phosphate shunt (GO:0006098) | 4.88920546 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 4.47112170 |
| 4 | * NADPH regeneration (GO:0006740) | 4.42794801 |
| 5 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.34850964 |
| 6 | viral transcription (GO:0019083) | 4.19447876 |
| 7 | translational termination (GO:0006415) | 4.03575288 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96562807 |
| 9 | protein localization to kinetochore (GO:0034501) | 3.87594160 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.85721110 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85721110 |
| 12 | regulation of translational fidelity (GO:0006450) | 3.84758585 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 3.80015871 |
| 14 | DNA strand elongation (GO:0022616) | 3.73009478 |
| 15 | glucose 6-phosphate metabolic process (GO:0051156) | 3.70943876 |
| 16 | translational elongation (GO:0006414) | 3.67182104 |
| 17 | response to peptidoglycan (GO:0032494) | 3.65004499 |
| 18 | IMP biosynthetic process (GO:0006188) | 3.63495504 |
| 19 | negative regulation of phagocytosis (GO:0050765) | 3.62277460 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60977993 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.57236192 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.57236192 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.57236192 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.57236192 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.57236192 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.57236192 |
| 27 | positive regulation of histone deacetylation (GO:0031065) | 3.57179577 |
| 28 | COPI coating of Golgi vesicle (GO:0048205) | 3.45179973 |
| 29 | Golgi transport vesicle coating (GO:0048200) | 3.45179973 |
| 30 | protein complex localization (GO:0031503) | 3.43403870 |
| 31 | DNA replication initiation (GO:0006270) | 3.39742864 |
| 32 | pinocytosis (GO:0006907) | 3.38883666 |
| 33 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.38353351 |
| 34 | mitotic chromosome condensation (GO:0007076) | 3.38170963 |
| 35 | IMP metabolic process (GO:0046040) | 3.38070886 |
| 36 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.35986901 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34844619 |
| 38 | regulation of protein heterodimerization activity (GO:0043497) | 3.32981633 |
| 39 | translational initiation (GO:0006413) | 3.31343238 |
| 40 | regulation of translational termination (GO:0006449) | 3.19186973 |
| 41 | cellular protein complex localization (GO:0034629) | 3.15951388 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 3.15035929 |
| 43 | viral life cycle (GO:0019058) | 3.14759317 |
| 44 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.14267676 |
| 45 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.13402737 |
| 46 | mitotic nuclear envelope disassembly (GO:0007077) | 3.13222500 |
| 47 | cellular protein complex disassembly (GO:0043624) | 3.13117772 |
| 48 | * glucose catabolic process (GO:0006007) | 3.12731985 |
| 49 | maternal placenta development (GO:0001893) | 3.12547646 |
| 50 | activation of Rac GTPase activity (GO:0032863) | 3.09057320 |
| 51 | regulation of cholesterol storage (GO:0010885) | 3.08521196 |
| 52 | white fat cell differentiation (GO:0050872) | 3.08318866 |
| 53 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.07080611 |
| 54 | protein targeting to ER (GO:0045047) | 3.06924151 |
| 55 | protein localization to endosome (GO:0036010) | 3.06896241 |
| 56 | ribosomal small subunit biogenesis (GO:0042274) | 3.04822065 |
| 57 | proline biosynthetic process (GO:0006561) | 3.03376047 |
| 58 | cotranslational protein targeting to membrane (GO:0006613) | 3.03077885 |
| 59 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.01917056 |
| 60 | formation of translation preinitiation complex (GO:0001731) | 3.00230142 |
| 61 | negative regulation of RNA splicing (GO:0033119) | 2.99833287 |
| 62 | DNA duplex unwinding (GO:0032508) | 2.99151397 |
| 63 | DNA geometric change (GO:0032392) | 2.95923403 |
| 64 | protein complex disassembly (GO:0043241) | 2.95409277 |
| 65 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.92891664 |
| 66 | defense response to fungus (GO:0050832) | 2.91386888 |
| 67 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.91176485 |
| 68 | T cell apoptotic process (GO:0070231) | 2.90907061 |
| 69 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.90609281 |
| 70 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.90609281 |
| 71 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.90273024 |
| 72 | nucleobase biosynthetic process (GO:0046112) | 2.89894076 |
| 73 | membrane disassembly (GO:0030397) | 2.89663045 |
| 74 | nuclear envelope disassembly (GO:0051081) | 2.89663045 |
| 75 | heterochromatin organization (GO:0070828) | 2.88714333 |
| 76 | positive regulation of protein deacetylation (GO:0090312) | 2.88239267 |
| 77 | translesion synthesis (GO:0019985) | 2.86608518 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86458302 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.84499465 |
| 80 | protein localization to endoplasmic reticulum (GO:0070972) | 2.84224625 |
| 81 | valine metabolic process (GO:0006573) | 2.84165923 |
| 82 | embryonic process involved in female pregnancy (GO:0060136) | 2.81441355 |
| 83 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.80856120 |
| 84 | establishment of integrated proviral latency (GO:0075713) | 2.79648924 |
| 85 | maturation of SSU-rRNA (GO:0030490) | 2.79405114 |
| 86 | pore complex assembly (GO:0046931) | 2.78569457 |
| 87 | cell-substrate adherens junction assembly (GO:0007045) | 2.78347319 |
| 88 | focal adhesion assembly (GO:0048041) | 2.78347319 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.77659747 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.76273135 |
| 91 | regulation of early endosome to late endosome transport (GO:2000641) | 2.76129312 |
| 92 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.76000466 |
| 93 | telomere maintenance via recombination (GO:0000722) | 2.75688438 |
| 94 | adherens junction assembly (GO:0034333) | 2.75389752 |
| 95 | biotin metabolic process (GO:0006768) | 2.72679458 |
| 96 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.71575827 |
| 97 | nuclear pore organization (GO:0006999) | 2.71189715 |
| 98 | protein export from nucleus (GO:0006611) | 2.70960656 |
| 99 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.70085236 |
| 100 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.68207086 |
| 101 | mitotic recombination (GO:0006312) | 2.66762041 |
| 102 | detection of other organism (GO:0098543) | 2.66486025 |
| 103 | macromolecular complex disassembly (GO:0032984) | 2.66155333 |
| 104 | acyl-CoA biosynthetic process (GO:0071616) | 2.65937480 |
| 105 | thioester biosynthetic process (GO:0035384) | 2.65937480 |
| 106 | respiratory burst (GO:0045730) | 2.65799548 |
| 107 | ncRNA 3-end processing (GO:0043628) | 2.64912287 |
| 108 | dosage compensation (GO:0007549) | 2.64675722 |
| 109 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.62436136 |
| 110 | tricarboxylic acid metabolic process (GO:0072350) | 2.61910942 |
| 111 | negative regulation of mRNA processing (GO:0050686) | 2.61005570 |
| 112 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.60857514 |
| 113 | modulation by virus of host process (GO:0019054) | 2.60647724 |
| 114 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.60588348 |
| 115 | UMP biosynthetic process (GO:0006222) | 2.60588348 |
| 116 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.60588348 |
| 117 | UMP metabolic process (GO:0046049) | 2.60588348 |
| 118 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.59218765 |
| 119 | stress fiber assembly (GO:0043149) | 2.58768181 |
| 120 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.58666914 |
| 121 | nuclear pore complex assembly (GO:0051292) | 2.58575714 |
| 122 | protein retention in ER lumen (GO:0006621) | 2.58188977 |
| 123 | modulation by symbiont of host cellular process (GO:0044068) | 2.58050597 |
| 124 | triglyceride catabolic process (GO:0019433) | 2.57549527 |
| 125 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.57432325 |
| 126 | histone arginine methylation (GO:0034969) | 2.57190286 |
| 127 | sister chromatid segregation (GO:0000819) | 2.56195115 |
| 128 | detection of bacterium (GO:0016045) | 2.55196703 |
| 129 | mRNA stabilization (GO:0048255) | 2.54889199 |
| 130 | RNA stabilization (GO:0043489) | 2.54889199 |
| 131 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.54606125 |
| 132 | mitotic sister chromatid segregation (GO:0000070) | 2.54502968 |
| 133 | mannose metabolic process (GO:0006013) | 2.54464415 |
| 134 | regulation of histone H3-K9 methylation (GO:0051570) | 2.54416000 |
| 135 | apoptotic process involved in morphogenesis (GO:0060561) | 2.53905021 |
| 136 | lymphocyte apoptotic process (GO:0070227) | 2.53669059 |
| 137 | triglyceride biosynthetic process (GO:0019432) | 2.53500231 |
| 138 | L-serine metabolic process (GO:0006563) | 2.52675639 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.51485401 |
| 140 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.50273588 |
| 141 | negative regulation of mRNA metabolic process (GO:1903312) | 2.48189881 |
| 142 | response to fungus (GO:0009620) | 2.47552734 |
| 143 | regulation of superoxide anion generation (GO:0032928) | 2.46318155 |
| 144 | tetrahydrofolate metabolic process (GO:0046653) | 2.46168056 |
| 145 | ribosomal large subunit biogenesis (GO:0042273) | 2.45518224 |
| 146 | response to host (GO:0075136) | 2.45498025 |
| 147 | response to host defenses (GO:0052200) | 2.45498025 |
| 148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45498025 |
| 149 | nuclear envelope organization (GO:0006998) | 2.44992818 |
| 150 | cellular hyperosmotic response (GO:0071474) | 2.44440748 |
| 151 | telomere maintenance via telomere lengthening (GO:0010833) | 2.43681901 |
| 152 | regulation of leukocyte degranulation (GO:0043300) | 2.42015277 |
| 153 | nucleosome disassembly (GO:0006337) | 2.41133816 |
| 154 | protein-DNA complex disassembly (GO:0032986) | 2.41133816 |
| 155 | cell-substrate junction assembly (GO:0007044) | 2.38980947 |
| 156 | response to host immune response (GO:0052572) | 2.38631070 |
| 157 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.38631070 |
| 158 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.36728049 |
| 159 | establishment of viral latency (GO:0019043) | 2.33720555 |
| 160 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.32390982 |
| 161 | cellular response to interleukin-4 (GO:0071353) | 2.30544663 |
| 162 | response to muramyl dipeptide (GO:0032495) | 2.27705888 |
| 163 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.26532849 |
| 164 | protein maturation by protein folding (GO:0022417) | 2.26491140 |
| 165 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.24507421 |
| 166 | regulation of RNA export from nucleus (GO:0046831) | 2.23998716 |
| 167 | basement membrane organization (GO:0071711) | 2.22816187 |
| 168 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.21893737 |
| 169 | pre-miRNA processing (GO:0031054) | 2.21671387 |
| 170 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.20979248 |
| 171 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.18173075 |
| 172 | leukocyte aggregation (GO:0070486) | 2.17698763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.52185802 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.72759531 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.70436232 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.42780715 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.87956913 |
| 6 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.77637470 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67515613 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52775115 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42647278 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.14736798 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09422427 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.04777676 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.79767367 |
| 14 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78307294 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.75388826 |
| 16 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75068694 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.74948350 |
| 18 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74742952 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.72461572 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69436378 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67792190 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66920289 |
| 23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.65093174 |
| 24 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62556761 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55326299 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54154285 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53540771 |
| 28 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.52202323 |
| 29 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51034078 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49594710 |
| 31 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.49410942 |
| 32 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48898917 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47536256 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47106305 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45848297 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42211537 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41717452 |
| 38 | * MAF_26560356_Chip-Seq_TH1_Human | 1.40938254 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39146411 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39140170 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38829722 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37295963 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36127998 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34514962 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33350216 |
| 46 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31735213 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27954027 |
| 48 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.27661896 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26093229 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25342113 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25317100 |
| 52 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24422885 |
| 53 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23832997 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23731656 |
| 55 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23472473 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23102776 |
| 57 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22242970 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22210880 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22174946 |
| 60 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22055150 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21679881 |
| 62 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21536658 |
| 63 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21452882 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20576655 |
| 65 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20516192 |
| 66 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19745997 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19569536 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19355809 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18663288 |
| 70 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.18035921 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17212179 |
| 72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16652290 |
| 73 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16116475 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16071955 |
| 75 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16049002 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15547413 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15464113 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15447716 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13478177 |
| 80 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.12925861 |
| 81 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12070036 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10332537 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09626829 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08932490 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08863541 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.08842301 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08573086 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08360629 |
| 89 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08147271 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.07817655 |
| 91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07190520 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06641820 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06133896 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04959120 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04656884 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04428178 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04307264 |
| 98 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04238584 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04088756 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03808186 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03460689 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03354617 |
| 103 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02760825 |
| 104 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02565075 |
| 105 | * MYB_26560356_Chip-Seq_TH2_Human | 1.02396142 |
| 106 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01471312 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01352298 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00801317 |
| 109 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00650138 |
| 110 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00469053 |
| 111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00356134 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 1.00350580 |
| 113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00343875 |
| 114 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.99435537 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98391577 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96995018 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96509547 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96301567 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96116324 |
| 120 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95854502 |
| 121 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93958430 |
| 122 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89801467 |
| 123 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.89361315 |
| 124 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86346022 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86062787 |
| 126 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.85296575 |
| 127 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.84590279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010352_gastrointestinal_tract_polyps | 2.97861095 |
| 2 | MP0008260_abnormal_autophagy | 2.84245905 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 2.72396914 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.67662448 |
| 5 | MP0003303_peritoneal_inflammation | 2.66209394 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.54280268 |
| 7 | MP0005670_abnormal_white_adipose | 2.53065868 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.47816294 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.44437130 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.42043442 |
| 11 | MP0005451_abnormal_body_composition | 2.40408761 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.37190690 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.35974157 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.28331832 |
| 15 | MP0010307_abnormal_tumor_latency | 2.19477028 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.11779387 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.09203569 |
| 18 | MP0004858_abnormal_nervous_system | 2.07279779 |
| 19 | MP0003077_abnormal_cell_cycle | 1.96650806 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.95705593 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.95705593 |
| 22 | MP0009840_abnormal_foam_cell | 1.94002338 |
| 23 | MP0000490_abnormal_crypts_of | 1.88022994 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.87894904 |
| 25 | MP0009278_abnormal_bone_marrow | 1.87094241 |
| 26 | MP0004233_abnormal_muscle_weight | 1.81891298 |
| 27 | MP0001730_embryonic_growth_arrest | 1.70974765 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.64700478 |
| 29 | MP0003436_decreased_susceptibility_to | 1.62468442 |
| 30 | MP0002796_impaired_skin_barrier | 1.61425128 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.61056324 |
| 32 | MP0005375_adipose_tissue_phenotype | 1.60629866 |
| 33 | MP0004130_abnormal_muscle_cell | 1.57270122 |
| 34 | MP0000685_abnormal_immune_system | 1.52565944 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.51180410 |
| 36 | MP0000350_abnormal_cell_proliferation | 1.46091027 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.42637020 |
| 38 | MP0006054_spinal_hemorrhage | 1.41282219 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.39735479 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.37363462 |
| 41 | MP0008057_abnormal_DNA_replication | 1.36641169 |
| 42 | * MP0002970_abnormal_white_adipose | 1.36411431 |
| 43 | MP0001881_abnormal_mammary_gland | 1.36202306 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.35152820 |
| 45 | MP0000858_altered_metastatic_potential | 1.34170375 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.33597457 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.31141682 |
| 48 | MP0002398_abnormal_bone_marrow | 1.30938181 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.29606416 |
| 50 | MP0009115_abnormal_fat_cell | 1.27423004 |
| 51 | MP0002971_abnormal_brown_adipose | 1.27289949 |
| 52 | MP0002019_abnormal_tumor_incidence | 1.26465377 |
| 53 | MP0001873_stomach_inflammation | 1.25253375 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.25229881 |
| 55 | MP0001915_intracranial_hemorrhage | 1.24601954 |
| 56 | MP0002722_abnormal_immune_system | 1.24193056 |
| 57 | MP0003091_abnormal_cell_migration | 1.23832592 |
| 58 | MP0005621_abnormal_cell_physiology | 1.22772398 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.21481321 |
| 60 | MP0005023_abnormal_wound_healing | 1.20767897 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.19499150 |
| 62 | MP0000609_abnormal_liver_physiology | 1.18417553 |
| 63 | MP0002060_abnormal_skin_morphology | 1.18038275 |
| 64 | MP0001853_heart_inflammation | 1.17017093 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.16832814 |
| 66 | * MP0002080_prenatal_lethality | 1.14318293 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.13090375 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.12315714 |
| 69 | MP0005025_abnormal_response_to | 1.12111580 |
| 70 | MP0002429_abnormal_blood_cell | 1.09937410 |
| 71 | MP0001800_abnormal_humoral_immune | 1.09227058 |
| 72 | MP0004197_abnormal_fetal_growth/weight/ | 1.09084318 |
| 73 | MP0003828_pulmonary_edema | 1.08811790 |
| 74 | MP0003448_altered_tumor_morphology | 1.08475609 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.07104170 |
| 76 | MP0003984_embryonic_growth_retardation | 1.05628980 |
| 77 | MP0001849_ear_inflammation | 1.05526296 |
| 78 | MP0002419_abnormal_innate_immunity | 1.05415682 |
| 79 | MP0001672_abnormal_embryogenesis/_devel | 1.05322077 |
| 80 | MP0005380_embryogenesis_phenotype | 1.05322077 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 1.04098874 |
| 82 | MP0002452_abnormal_antigen_presenting | 1.03685001 |
| 83 | MP0002420_abnormal_adaptive_immunity | 1.02519390 |
| 84 | MP0003186_abnormal_redox_activity | 1.01629926 |
| 85 | MP0000716_abnormal_immune_system | 1.01575895 |
| 86 | MP0002086_abnormal_extraembryonic_tissu | 1.01472522 |
| 87 | MP0002405_respiratory_system_inflammati | 1.01188287 |
| 88 | MP0001819_abnormal_immune_cell | 1.01131338 |
| 89 | MP0004947_skin_inflammation | 1.00974778 |
| 90 | MP0001697_abnormal_embryo_size | 1.00627628 |
| 91 | MP0008007_abnormal_cellular_replicative | 1.00558854 |
| 92 | MP0000477_abnormal_intestine_morphology | 1.00527918 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.99687543 |
| 94 | MP0004272_abnormal_basement_membrane | 0.97632713 |
| 95 | MP0005384_cellular_phenotype | 0.95489962 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.95252555 |
| 97 | MP0005083_abnormal_biliary_tract | 0.94172181 |
| 98 | MP0008932_abnormal_embryonic_tissue | 0.94063098 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.93585550 |
| 100 | MP0009785_altered_susceptibility_to | 0.93564860 |
| 101 | MP0000703_abnormal_thymus_morphology | 0.92779398 |
| 102 | MP0009672_abnormal_birth_weight | 0.92392270 |
| 103 | MP0000537_abnormal_urethra_morphology | 0.92287769 |
| 104 | MP0003123_paternal_imprinting | 0.91777281 |
| 105 | MP0002132_abnormal_respiratory_system | 0.91352966 |
| 106 | MP0000313_abnormal_cell_death | 0.91349988 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.90970666 |
| 108 | MP0005334_abnormal_fat_pad | 0.90736435 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.90187578 |
| 110 | MP0003763_abnormal_thymus_physiology | 0.89791210 |
| 111 | MP0001661_extended_life_span | 0.88618911 |
| 112 | MP0003866_abnormal_defecation | 0.88444240 |
| 113 | MP0009053_abnormal_anal_canal | 0.88389516 |
| 114 | MP0001851_eye_inflammation | 0.87826690 |
| 115 | MP0005501_abnormal_skin_physiology | 0.87566479 |
| 116 | * MP0000598_abnormal_liver_morphology | 0.87134834 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.86383052 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.84651754 |
| 119 | MP0002006_tumorigenesis | 0.84044903 |
| 120 | MP0002085_abnormal_embryonic_tissue | 0.83890876 |
| 121 | MP0002723_abnormal_immune_serum | 0.83876874 |
| 122 | MP0002254_reproductive_system_inflammat | 0.83805078 |
| 123 | MP0009931_abnormal_skin_appearance | 0.83799201 |
| 124 | MP0010030_abnormal_orbit_morphology | 0.83145025 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.82895703 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82895661 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.81472082 |
| 128 | MP0003941_abnormal_skin_development | 0.81322781 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.80925940 |
| 130 | MP0002009_preneoplasia | 0.80859211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.32882037 |
| 2 | Reticulocytopenia (HP:0001896) | 3.31492726 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 3.12472936 |
| 4 | Vertebral compression fractures (HP:0002953) | 3.05063619 |
| 5 | Thrombocytosis (HP:0001894) | 3.01625362 |
| 6 | Multiple enchondromatosis (HP:0005701) | 2.97205787 |
| 7 | Eczematoid dermatitis (HP:0000976) | 2.84153878 |
| 8 | Broad face (HP:0000283) | 2.74525778 |
| 9 | Spastic diplegia (HP:0001264) | 2.66569633 |
| 10 | Hyperacusis (HP:0010780) | 2.66524675 |
| 11 | Selective tooth agenesis (HP:0001592) | 2.64556397 |
| 12 | Cellulitis (HP:0100658) | 2.60136603 |
| 13 | Long palpebral fissure (HP:0000637) | 2.60001397 |
| 14 | Ependymoma (HP:0002888) | 2.59391669 |
| 15 | Abnormal platelet volume (HP:0011876) | 2.57822903 |
| 16 | Chronic otitis media (HP:0000389) | 2.56977420 |
| 17 | Hypertriglyceridemia (HP:0002155) | 2.51167461 |
| 18 | Premature rupture of membranes (HP:0001788) | 2.46666058 |
| 19 | Abnormality of reticulocytes (HP:0004312) | 2.46634310 |
| 20 | Increased mean platelet volume (HP:0011877) | 2.43995771 |
| 21 | Cholecystitis (HP:0001082) | 2.40105340 |
| 22 | Abnormal gallbladder physiology (HP:0012438) | 2.40105340 |
| 23 | Increased density of long bones (HP:0006392) | 2.37493446 |
| 24 | Increased connective tissue (HP:0009025) | 2.35000932 |
| 25 | Petechiae (HP:0000967) | 2.34048734 |
| 26 | Disproportionate tall stature (HP:0001519) | 2.33160303 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.30242128 |
| 28 | Protrusio acetabuli (HP:0003179) | 2.27620499 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.25544755 |
| 30 | Subacute progressive viral hepatitis (HP:0006572) | 2.25345542 |
| 31 | Upper motor neuron abnormality (HP:0002127) | 2.24012736 |
| 32 | IgM deficiency (HP:0002850) | 2.23488829 |
| 33 | Abnormality of oral frenula (HP:0000190) | 2.22090231 |
| 34 | Achilles tendon contracture (HP:0001771) | 2.20846065 |
| 35 | Pallor (HP:0000980) | 2.18661140 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 2.18652529 |
| 37 | Ulnar bowing (HP:0003031) | 2.15947246 |
| 38 | High pitched voice (HP:0001620) | 2.14407682 |
| 39 | Ankyloglossia (HP:0010296) | 2.14124612 |
| 40 | Pseudobulbar signs (HP:0002200) | 2.13568636 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.13486462 |
| 42 | Basal cell carcinoma (HP:0002671) | 2.04852814 |
| 43 | Micronodular cirrhosis (HP:0001413) | 2.02488992 |
| 44 | Hyperglycinuria (HP:0003108) | 2.02479860 |
| 45 | Metaphyseal cupping (HP:0003021) | 2.02030629 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.01705722 |
| 47 | Progressive muscle weakness (HP:0003323) | 2.01198483 |
| 48 | Macrocytic anemia (HP:0001972) | 2.00849518 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.00109098 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00105638 |
| 51 | Rhabdomyolysis (HP:0003201) | 1.99219644 |
| 52 | Reticulocytosis (HP:0001923) | 1.98901451 |
| 53 | Angiofibromas (HP:0010615) | 1.98852557 |
| 54 | Adenoma sebaceum (HP:0009720) | 1.98852557 |
| 55 | Rectal prolapse (HP:0002035) | 1.98634691 |
| 56 | Myocardial infarction (HP:0001658) | 1.98049089 |
| 57 | Acanthosis nigricans (HP:0000956) | 1.95630231 |
| 58 | Ankle contracture (HP:0006466) | 1.95375941 |
| 59 | Progressive external ophthalmoplegia (HP:0000590) | 1.95055975 |
| 60 | Recurrent fungal infections (HP:0002841) | 1.94743686 |
| 61 | Verrucae (HP:0200043) | 1.94076059 |
| 62 | Papilloma (HP:0012740) | 1.94076059 |
| 63 | Agnosia (HP:0010524) | 1.93542408 |
| 64 | Cutaneous melanoma (HP:0012056) | 1.92267735 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 1.92211728 |
| 66 | Flat acetabular roof (HP:0003180) | 1.91349131 |
| 67 | Colon cancer (HP:0003003) | 1.90863042 |
| 68 | Abnormality of the Achilles tendon (HP:0005109) | 1.90159216 |
| 69 | Hepatosplenomegaly (HP:0001433) | 1.89824051 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89195122 |
| 71 | Obstructive lung disease (HP:0006536) | 1.89195122 |
| 72 | Viral hepatitis (HP:0006562) | 1.89192102 |
| 73 | Hand muscle atrophy (HP:0009130) | 1.89112975 |
| 74 | Increased serum ferritin (HP:0003281) | 1.89068096 |
| 75 | Impaired platelet aggregation (HP:0003540) | 1.88233131 |
| 76 | Abnormal platelet function (HP:0011869) | 1.88233131 |
| 77 | Nasal polyposis (HP:0100582) | 1.88070162 |
| 78 | Recurrent viral infections (HP:0004429) | 1.87437312 |
| 79 | Gingivitis (HP:0000230) | 1.87130118 |
| 80 | Short nail (HP:0001799) | 1.86928480 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.86355126 |
| 82 | Prolonged bleeding time (HP:0003010) | 1.83136087 |
| 83 | Pustule (HP:0200039) | 1.82814635 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 1.80706583 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.80706583 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 1.80495546 |
| 87 | Ragged-red muscle fibers (HP:0003200) | 1.79869034 |
| 88 | Deviation of the thumb (HP:0009603) | 1.79663303 |
| 89 | Proximal placement of thumb (HP:0009623) | 1.79583422 |
| 90 | Polygenic inheritance (HP:0010982) | 1.79128316 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78223951 |
| 92 | Asymmetry of the thorax (HP:0001555) | 1.78118012 |
| 93 | Syringomyelia (HP:0003396) | 1.77895976 |
| 94 | Spinal cord lesions (HP:0100561) | 1.77895976 |
| 95 | Abnormality of the thoracic spine (HP:0100711) | 1.77291566 |
| 96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76556975 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76285586 |
| 98 | Poikiloderma (HP:0001029) | 1.75302060 |
| 99 | Increased nuchal translucency (HP:0010880) | 1.75119645 |
| 100 | Abnormality of macrophages (HP:0004311) | 1.74801355 |
| 101 | Shallow orbits (HP:0000586) | 1.73416523 |
| 102 | Loss of speech (HP:0002371) | 1.73117937 |
| 103 | Abnormality of the nasal mucosa (HP:0000433) | 1.72300271 |
| 104 | Distal lower limb muscle weakness (HP:0009053) | 1.71793264 |
| 105 | Biconcave vertebral bodies (HP:0004586) | 1.71687788 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71284701 |
| 107 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71261539 |
| 108 | Amyloidosis (HP:0011034) | 1.71233807 |
| 109 | Fatigue (HP:0012378) | 1.70957544 |
| 110 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70900013 |
| 111 | Osteolytic defects of the hand bones (HP:0009699) | 1.70900013 |
| 112 | Astrocytoma (HP:0009592) | 1.69382727 |
| 113 | Abnormality of the astrocytes (HP:0100707) | 1.69382727 |
| 114 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.68003939 |
| 115 | Inflammation of the large intestine (HP:0002037) | 1.67672938 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 1.67261824 |
| 117 | Amaurosis fugax (HP:0100576) | 1.66703835 |
| 118 | Abnormality of the calcaneus (HP:0008364) | 1.66426030 |
| 119 | Colitis (HP:0002583) | 1.65846110 |
| 120 | Urticaria (HP:0001025) | 1.65632584 |
| 121 | Broad distal phalanx of finger (HP:0009836) | 1.65605983 |
| 122 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.64967842 |
| 123 | Dysmetric saccades (HP:0000641) | 1.64938237 |
| 124 | Arnold-Chiari malformation (HP:0002308) | 1.64602269 |
| 125 | Pointed chin (HP:0000307) | 1.63945962 |
| 126 | Abnormality of the peritoneum (HP:0002585) | 1.63535044 |
| 127 | Thoracic kyphosis (HP:0002942) | 1.61368785 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.61321520 |
| 129 | Elfin facies (HP:0004428) | 1.60955043 |
| 130 | Large hands (HP:0001176) | 1.59993128 |
| 131 | Rough bone trabeculation (HP:0100670) | 1.59853738 |
| 132 | Short 4th metacarpal (HP:0010044) | 1.59772305 |
| 133 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.59772305 |
| 134 | Myoglobinuria (HP:0002913) | 1.59606984 |
| 135 | Back pain (HP:0003418) | 1.59588093 |
| 136 | Insulin resistance (HP:0000855) | 1.59558627 |
| 137 | Blue sclerae (HP:0000592) | 1.59456852 |
| 138 | Polycythemia (HP:0001901) | 1.59441341 |
| 139 | Microvesicular hepatic steatosis (HP:0001414) | 1.59255155 |
| 140 | Skin ulcer (HP:0200042) | 1.58658561 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 1.58469573 |
| 142 | Fasciculations (HP:0002380) | 1.58058208 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.57813016 |
| 144 | Pathologic fracture (HP:0002756) | 1.57556448 |
| 145 | Patellar dislocation (HP:0002999) | 1.57493950 |
| 146 | Increased IgE level (HP:0003212) | 1.56623302 |
| 147 | Bowing of the arm (HP:0006488) | 1.56577882 |
| 148 | Bowed forearm bones (HP:0003956) | 1.56577882 |
| 149 | Fibroma (HP:0010614) | 1.56519109 |
| 150 | Lower limb amyotrophy (HP:0007210) | 1.56220909 |
| 151 | Enlarged penis (HP:0000040) | 1.55570586 |
| 152 | Myositis (HP:0100614) | 1.55112720 |
| 153 | Oral leukoplakia (HP:0002745) | 1.54725549 |
| 154 | Trismus (HP:0000211) | 1.54322689 |
| 155 | Cervical subluxation (HP:0003308) | 1.54223279 |
| 156 | Abnormality of T cells (HP:0002843) | 1.53328539 |
| 157 | Distal upper limb amyotrophy (HP:0007149) | 1.53159630 |
| 158 | Upper limb amyotrophy (HP:0009129) | 1.53159630 |
| 159 | Insomnia (HP:0100785) | 1.52888230 |
| 160 | Mediastinal lymphadenopathy (HP:0100721) | 1.52670655 |
| 161 | Abnormal vertebral ossification (HP:0100569) | 1.52160034 |
| 162 | Gastrointestinal dysmotility (HP:0002579) | 1.51314982 |
| 163 | Advanced eruption of teeth (HP:0006288) | 1.51002638 |
| 164 | Flared metaphyses (HP:0003015) | 1.50885733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.36593125 |
| 2 | EEF2K | 4.33904014 |
| 3 | SMG1 | 4.16307941 |
| 4 | PKN2 | 3.72145579 |
| 5 | PRPF4B | 2.87794791 |
| 6 | CAMK1D | 2.73490474 |
| 7 | MAP3K10 | 2.38382021 |
| 8 | IRAK3 | 2.33741758 |
| 9 | ERN1 | 2.26908956 |
| 10 | CDC7 | 2.18045406 |
| 11 | MAP4K1 | 2.14404843 |
| 12 | SCYL2 | 2.13395136 |
| 13 | LRRK2 | 2.12958974 |
| 14 | TESK2 | 2.11931600 |
| 15 | SIK1 | 2.01714975 |
| 16 | STK10 | 1.88468371 |
| 17 | NEK2 | 1.84236999 |
| 18 | RPS6KB2 | 1.83496210 |
| 19 | WEE1 | 1.72589398 |
| 20 | RIPK4 | 1.69658715 |
| 21 | FLT3 | 1.64613221 |
| 22 | CAMK1G | 1.63731806 |
| 23 | PAK4 | 1.57099114 |
| 24 | BUB1 | 1.56575938 |
| 25 | IRAK4 | 1.55565805 |
| 26 | GRK6 | 1.54156638 |
| 27 | BCKDK | 1.50978526 |
| 28 | CDK12 | 1.49872885 |
| 29 | MST1R | 1.45761169 |
| 30 | MAP3K8 | 1.43743860 |
| 31 | PTK6 | 1.40560614 |
| 32 | NEK1 | 1.39862515 |
| 33 | CDK4 | 1.35244339 |
| 34 | KSR2 | 1.34980831 |
| 35 | NME2 | 1.33123352 |
| 36 | ALK | 1.28986690 |
| 37 | CDK6 | 1.25007976 |
| 38 | EPHB1 | 1.19788051 |
| 39 | TAOK2 | 1.18768004 |
| 40 | MAP3K3 | 1.17279192 |
| 41 | BTK | 1.13996595 |
| 42 | RIPK1 | 1.13812609 |
| 43 | BMX | 1.13271897 |
| 44 | BLK | 1.10946567 |
| 45 | MAP3K13 | 1.10796350 |
| 46 | ARAF | 1.06794794 |
| 47 | RPS6KA4 | 1.03195305 |
| 48 | TSSK6 | 1.02559230 |
| 49 | CSF1R | 0.98605853 |
| 50 | PASK | 0.98378183 |
| 51 | LATS2 | 0.96789901 |
| 52 | CDK7 | 0.96636530 |
| 53 | TTN | 0.96179802 |
| 54 | TESK1 | 0.96059240 |
| 55 | IRAK2 | 0.94583539 |
| 56 | MAP2K3 | 0.93162655 |
| 57 | TTK | 0.92810346 |
| 58 | PBK | 0.92721305 |
| 59 | ZAP70 | 0.89764927 |
| 60 | EPHA2 | 0.85056797 |
| 61 | BRAF | 0.83761311 |
| 62 | MAP3K1 | 0.83239150 |
| 63 | MTOR | 0.83152034 |
| 64 | TLK1 | 0.83016450 |
| 65 | PTK2 | 0.80472512 |
| 66 | ILK | 0.79395033 |
| 67 | PIM1 | 0.78963735 |
| 68 | FGR | 0.78729715 |
| 69 | VRK2 | 0.78459025 |
| 70 | ERBB4 | 0.77952117 |
| 71 | TGFBR1 | 0.77631553 |
| 72 | PRKD2 | 0.77414590 |
| 73 | KIT | 0.76979337 |
| 74 | ATR | 0.75721189 |
| 75 | MAPKAPK3 | 0.75697721 |
| 76 | TYK2 | 0.75236126 |
| 77 | EIF2AK1 | 0.74314964 |
| 78 | JAK3 | 0.73720936 |
| 79 | PDPK1 | 0.73279047 |
| 80 | PAK2 | 0.72979628 |
| 81 | MARK2 | 0.72671217 |
| 82 | STK4 | 0.69680198 |
| 83 | MATK | 0.69344773 |
| 84 | MAPK11 | 0.68897080 |
| 85 | KDR | 0.68359025 |
| 86 | AURKB | 0.67611175 |
| 87 | CLK1 | 0.65696837 |
| 88 | MAP3K11 | 0.65358251 |
| 89 | ICK | 0.65301860 |
| 90 | CDK19 | 0.64094858 |
| 91 | TBK1 | 0.63171660 |
| 92 | MET | 0.62702326 |
| 93 | RAF1 | 0.62516764 |
| 94 | PIM2 | 0.61632195 |
| 95 | MAP3K9 | 0.59978083 |
| 96 | CSK | 0.59565849 |
| 97 | PAK1 | 0.58728799 |
| 98 | RPS6KA2 | 0.57063945 |
| 99 | JAK2 | 0.56538068 |
| 100 | SIK3 | 0.53360848 |
| 101 | CHEK1 | 0.53332542 |
| 102 | CHEK2 | 0.52929045 |
| 103 | DYRK3 | 0.52373276 |
| 104 | PLK1 | 0.51856717 |
| 105 | FGFR4 | 0.51358113 |
| 106 | NTRK1 | 0.51117751 |
| 107 | CDK9 | 0.51088942 |
| 108 | MAP3K6 | 0.49866354 |
| 109 | YES1 | 0.47641266 |
| 110 | SRPK1 | 0.47456910 |
| 111 | PDK3 | 0.46122249 |
| 112 | PDK4 | 0.46122249 |
| 113 | TNK2 | 0.45213954 |
| 114 | HCK | 0.45088666 |
| 115 | AKT2 | 0.44517777 |
| 116 | SYK | 0.43087498 |
| 117 | MAP3K14 | 0.42944827 |
| 118 | PDGFRA | 0.42013480 |
| 119 | BRSK2 | 0.41288470 |
| 120 | CDC42BPA | 0.40656151 |
| 121 | AURKA | 0.40566843 |
| 122 | LCK | 0.39924402 |
| 123 | MAP2K2 | 0.39499226 |
| 124 | LMTK2 | 0.39476435 |
| 125 | CDK2 | 0.39047192 |
| 126 | RPS6KC1 | 0.38165784 |
| 127 | RPS6KL1 | 0.38165784 |
| 128 | RPS6KA1 | 0.37806198 |
| 129 | ACVR1B | 0.37370872 |
| 130 | RPS6KA6 | 0.37167944 |
| 131 | PRKAA2 | 0.36746440 |
| 132 | FGFR1 | 0.36336278 |
| 133 | RET | 0.36230024 |
| 134 | PRKG2 | 0.35470902 |
| 135 | TAOK1 | 0.34756703 |
| 136 | CSNK2A2 | 0.34571916 |
| 137 | FES | 0.33921517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.91563346 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.85794444 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.69638197 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.38805998 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.34004685 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.25420598 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14837588 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12496422 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 1.85088644 |
| 10 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.84736145 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 1.81753052 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76025826 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.74709050 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74548252 |
| 15 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.70156646 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60600439 |
| 17 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56057755 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55962502 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.52084297 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51407246 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.48877804 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47103352 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43026120 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39574042 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.36611741 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34907368 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31437236 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28279832 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27809352 |
| 30 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.24234349 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21627667 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21244966 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.20098826 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18522188 |
| 35 | Adherens junction_Homo sapiens_hsa04520 | 1.09467588 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09351390 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09299475 |
| 38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06917784 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05152754 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04674107 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04372730 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03153551 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03000145 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02897985 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01769117 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98572530 |
| 47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97450192 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96996745 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96339423 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91884902 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91876463 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90583346 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90124055 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.88469619 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87732627 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87643662 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87078997 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.87032736 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86817971 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86712526 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.86298720 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85229784 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.85062296 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83620702 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.82437701 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82136536 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82045758 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82008709 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81422920 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.79903163 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.78644407 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78570017 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.78504364 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77347338 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76480272 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.76280089 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.75162496 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.73707365 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72865287 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.72111912 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71494030 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.71376896 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.71282885 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71012292 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.70238668 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68712961 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.67668090 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67210834 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66896149 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66842741 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65024260 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64376128 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63503978 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62619567 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62497581 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62403652 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62019145 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.61971745 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.61797204 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61575266 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61532910 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60969437 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60799207 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60136178 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58834182 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58655698 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57981826 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56736567 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55747474 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55722399 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55156030 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54738167 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54571178 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53150627 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52905892 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.52856162 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52578954 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52483423 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52020506 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50451298 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49959396 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49128095 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48999874 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47744056 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46921348 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46568636 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46265793 |
| 128 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46221994 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.45411332 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44246614 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42218044 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40830787 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.40554771 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39115973 |

